GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Other Operating Expense

Biovica International AB (OSTO:BIOVIC B) Other Operating Expense : kr95.53 Mil (TTM As of Apr. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Other Operating Expense?

Biovica International AB's Other Operating Expense for the three months ended in Apr. 2025 was kr23.73 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Apr. 2025 was kr95.53 Mil.

Biovica International AB's quarterly Other Operating Expense increased from Oct. 2024 (kr22.44 Mil) to Jan. 2025 (kr24.24 Mil) but then declined from Jan. 2025 (kr24.24 Mil) to Apr. 2025 (kr23.73 Mil).

Biovica International AB's annual Other Operating Expense increased from Apr. 2023 (kr115.54 Mil) to Apr. 2024 (kr134.74 Mil) but then declined from Apr. 2024 (kr134.74 Mil) to Apr. 2025 (kr96.27 Mil).


Biovica International AB Other Operating Expense Historical Data

The historical data trend for Biovica International AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Other Operating Expense Chart

Biovica International AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.48 65.97 115.54 134.74 96.27

Biovica International AB Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.09 25.12 22.44 24.24 23.73

Biovica International AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr95.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines